Abstract
BackgroundThe preclinical screening of immune-modulatory therapies suffers from the absence of models that recapitulate in vivo heterogeneous tumor microenvironment (TME). 3D tumor organoid cultures provide a model that closely mimics...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have